Intrexon Closes Succesful IPO
Monday, August 19, 2013
Intrexon closed its initial public offering last week raising $184
million in gross proceeds. The company went public on August 8, trading
under the symbol XON.
The synthetic biology firm, that relocated
the Roanoke region in 2004, sold about 11.5 million shares of its common
stock at $16 per share. About 10 million shares were sold as part of
the initial offering, and another 1.5 million shares were sold to the
underwriters of the offering as part of their overallotment option. Of
that investment, approximately $30 million came from Randal J. Kirk, CEO
The stock more than doubled during its first week on the market, topping at over $29 per share.